摘要 |
This invention is in the field of IGF-1 modifications. In particular, it relates to modified IGF- polypeptides and modified IGF-1 precursor polypeptides wherein the cleavage of E-peptide is prevented. The invention also relates to the use of such polypeptides for treating muscle diseases and disorders. |